FDA: Lilly Drug Did Not Lead To Suicide
The Food and Drug Administration has concluded that Eli Lilly and Co.’s newly approved antidepressant Cymbalta did not trigger the suicide of a woman from Bensalem, Pa., who was taking part in a clinical trial. An FDA investigation found that Cymbalta could not be linked to the death of Traci Johnson, who hanged herself with a scarf in Lilly’s Indianapolis drug-testing clinic.
(1 votes, average: 1 out of 5)
Loading ...You can skip to the end and leave a response. Pinging is currently not allowed.
Join the Conversation! Post a Comment:
Last reviewed: By John M. Grohol, Psy.D. on 18 Aug 2004
